BrightGene Bio-Medical Technology Co., Ltd. (SHA:688166)
35.23
-0.89 (-2.46%)
At close: Sep 11, 2026
| Market Cap | 15.33B -60.3% |
| Revenue (ttm) | 1.36B +17.4% |
| Net Income | 96.27M -3.7% |
| EPS | 0.23 -2.0% |
| Shares Out | 435.23M |
| PE Ratio | 151.92 |
| Forward PE | n/a |
| Dividend | 0.02 (0.05%) |
| Ex-Dividend Date | Jun 9, 2026 |
| Volume | 7,385,100 |
| Open | 36.25 |
| Previous Close | 36.12 |
| Day's Range | 34.63 - 36.40 |
| 52-Week Range | 28.74 - 102.74 |
| Beta | 0.24 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 31, 2026 |